{"id":"W2132364830","doi":"10.1200/jco.2014.57.6926","title":"Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute; Pfizer","keywords":"Medicine; Anastrozole; Exemestane; Vasomotor; Aromatase inhibitor; Breast cancer; Internal medicine; Adverse effect; Common Terminology Criteria for Adverse Events; Tamoxifen; Cancer; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00251437,0.0001906925,0.000784227,0.00005159851,0.00005956336,0.00001978558,0.0002179553,0.0006554128,0.000007427805],"category_scores_gemma":[0.001536971,0.0001096773,0.0002899894,0.00007406431,0.0002507765,0.00001104185,0.00009299785,0.0005225508,0.000001940681],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004979106,"about_ca_system_score_gemma":0.0003406593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000559796,"about_ca_topic_score_gemma":0.0001567235,"domain_scores_codex":[0.9968475,0.00141383,0.001029043,0.0002543478,0.0001999114,0.000255364],"domain_scores_gemma":[0.9978813,0.0008425625,0.0007433776,0.0002328401,0.00008410647,0.0002158223],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.171546,0.01177309,0.2433717,0.00009484412,0.004015211,0.001082904,0.0005014335,0.00003628768,0.03122776,0.0004535239,0.01453565,0.5213616],"study_design_scores_gemma":[0.3180854,0.1096485,0.5050241,0.0001734056,0.001538578,0.001548338,0.0002691296,0.0002726894,0.0007573773,0.0005244144,0.06143266,0.0007254881],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940072,0.001670886,0.000004166969,0.002440511,0.001341853,0.000277481,0.00003804107,0.000003513766,0.0002163938],"genre_scores_gemma":[0.9949901,0.002872981,0.0000637466,0.0002732878,0.001679622,0.00001125946,0.00001675606,0.00001682551,0.0000754456],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5206361,"threshold_uncertainty_score":0.5055143,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02097737467456347,"score_gpt":0.3624859293299106,"score_spread":0.3415085546553471,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}